open access

Ahead of Print
Clinical vignette
Published online: 2020-12-15
Get Citation

Long-term response to hormone therapy in a young woman with aggressive pelvic angiomyxoma

Klaudia Walczak, Kamila Luczynska, Jolanta Kupryjanczyk, Renata Duchnowska
DOI: 10.5603/GP.a2020.0183
·
Pubmed: 33448013

open access

Ahead of Print
CLINICAL VIGNETTES
Published online: 2020-12-15

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

aggressive angiomyxoma, antiestrogen therapy, pelvic tumor

About this article
Title

Long-term response to hormone therapy in a young woman with aggressive pelvic angiomyxoma

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Clinical vignette

Published online

2020-12-15

DOI

10.5603/GP.a2020.0183

Pubmed

33448013

Keywords

aggressive angiomyxoma
antiestrogen therapy
pelvic tumor

Authors

Klaudia Walczak
Kamila Luczynska
Jolanta Kupryjanczyk
Renata Duchnowska

References (17)
  1. Chen H, Zhao H, Xie Y, et al. Clinicopathological features and differential diagnosis of aggressive angiomyxoma of the female pelvis: 5 case reports and literature review. Medicine (Baltimore). 2017; 96(20): e6820.
  2. Sun Y, Zhu L, Chang X, et al. Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum - a Retrospective Study. Pathol Oncol Res. 2017; 23(1): 131–137.
  3. Haldar K, Martinek IE, Kehoe S. Aggressive angiomyxoma: a case series and literature review. Eur J Surg Oncol. 2010; 36(4): 335–339.
  4. Schwartz PE, Hui P, McCarthy S. Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm. J Low Genit Tract Dis. 2014; 18(2): E55–E61.
  5. Hajjar R, Alharthi M, Richard C, et al. Pelvic Aggressive Angiomyxoma: Major Challenges in Diagnosis and Treatment. Cureus. 2019; 11(4): e4419.
  6. Aguilar-Frasco J, Ruben-Castillo C, Rodríguez-Quintero JH, et al. Aggressive angiomyxoma: giant recurrence successfully treated with wide excision and adjuvant therapy with GnRH analogue. BMJ Case Rep. 2018; 11(1).
  7. Alobaid A, Goffin F, Lussier C, et al. Aggressive Angiomyxoma of the Vulva or Perineum: Report of Three Patients. J Obstet Gynaecol Can. 2005; 27(11): 1023–1026.
  8. Aye C, Jefferis H, Chung DY, et al. A case of multi-modal managed vulval aggressive angiomyxoma diagnosed before conception and monitored during pregnancy. Gynecol Oncol. 2009; 115(1): 170–171.
  9. Bai HM, Yang JX, Huang HF, et al. Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis. Eur J Surg Oncol. 2013; 39(10): 1101–1108.
  10. Fine BA, Munoz AK, Litz CE, et al. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001; 81(1): 120–122.
  11. Fucà G, Hindi N, Ray-Coquard I, et al. Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. Oncologist. 2019; 24(7): e536–e541.
  12. Im SW, Han SSu. Treatment of aggressive angiomyxoma of the female perineum: Combined operative and hormone therapy. J Obstet Gynaecol. 2016; 36(6): 819–821.
  13. McCluggage WG, Jamieson T, Dobbs SP, et al. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy. Gynecol Oncol. 2006; 100(3): 623–625.
  14. Palomba S, Oppedisano R, Annunziata G, et al. Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: a case report. Gynecol Oncol. 2011; 123(1): 172–173.
  15. Abu JI, Bamford WM, Malin G, et al. Aggressive angiomyxoma of the perineum. Int J Gynecol Cancer. 2005; 15(6): 1097–1100.
  16. Magtibay PM, Salmon Z, Keeney GL, et al. Aggressive angiomyxoma of the female pelvis and perineum: a case series. Int J Gynecol Cancer. 2006; 16(1): 396–401.
  17. Giles DL, Liu PT, Lidner TK, et al. Treatment of aggressive angiomyxoma with aromatase inhibitor prior to surgical resection. Int J Gynecol Cancer. 2008; 18(2): 375–379.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl